Folgen
Michael Wilke
Michael Wilke
Professor für Krankenhausmanagement, Medical School Hamburg
Bestätigte E-Mail-Adresse bei d-w-g.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals
A Resch, M Wilke, C Fink
The European Journal of Health Economics 10 (3), 287-297, 2009
1112009
Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non …
MH Wilke, RF Grube, KF Bodmann
European journal of medical research 16, 315-323, 2011
992011
Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy
M Wilke, R Grube
Infection and drug resistance, 1-7, 2013
742013
The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients-a DRG-based simulation model
MH Wilke, RF Grube, KF Bodmann
European Journal of Medical Research 16, 543-548, 2011
582011
Multiresistant bacteria and current therapy-the economical side of the story
MH Wilke
European journal of medical research 15, 571-576, 2010
572010
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs-review of the literature
MH Wilke
European journal of medical research 16, 180-186, 2011
432011
Die Einführung des neuen DRG-basierten Entgeltsystems in Deutschen Krankenhäusern–Eine schwierige Operation? Erfahrungen und Lösungsansätze aus der Sicht der Unfallchirurgie …
MH Wilke, E Höcherl, J Scherer, L Janke
Der Unfallchirurg 104, 372-379, 2001
262001
Potential savings through single-dose intravenous dalbavancin in long-term MRSA infection treatment–a health economic analysis using German DRG data
M Wilke, K Worf, B Preisendörfer, W Heinlein, T Kast, KF Bodmann
GMS infectious diseases 7, 2019
222019
Introducing the new DRG-based payment system in German hospitals: a difficult operation? Experience and attempts at a solution from a surgery point of view
MH Wilke, EFJ Höcherl, J Scherer, L Janke
The European Journal of Health Economics (HEPAC) 2, 79-85, 2001
222001
Economic burden of Clostridium difficile enterocolitis in German hospitals based on routine DRG data
RF Grube, W Heinlein, H Scheffer, M Rathmayer, W Schepp, AW Lohse, ...
Zeitschrift fur Gastroenterologie 53 (5), 391-397, 2015
182015
Ökonomische Auswirkungen einer Clostridium-difficile-Enterokolitis in deutschen Krankenhäusern auf der Basis von DRG-Kostendaten
RF Grube, W Heinlein, H Scheffer, M Rathmayer, W Schepp, AW Lohse, ...
Zeitschrift für Gastroenterologie 53 (05), 391-397, 2015
182015
Invasive Fungal Infections in Infants—Focus on Anidulafungin
MH Wilke
Clinical Medicine Insights: Pediatrics 7, CMPed. S8028, 2013
152013
Detection and documentation of DRG-relevant comorbidities using laboratory tests
MH Wilke, M Schenker, G Hoffmann
Australian Health Review 25 (3), 152-160, 2002
142002
Introduction of the new DRG-based reimbursement system in German hospitals--a difficult operation? Experiences and possible solutions from the viewpoint of trauma surgery
MH Wilke, E Höcherl, J Scherer, L Janke
Der Unfallchirurg 104 (5), 372-379, 2001
142001
Cost assessment for endoscopic procedures in the German diagnosis-related-group (DRG) system-5 year cost data analysis of the German Society of Gastroenterology project
M Rathmayer, W Heinlein, C Reiss, JG Albert, B Akoglu, M Braun, ...
Zeitschrift fur Gastroenterologie 55 (10), 1038-1051, 2017
132017
Current strategies against multi-drug resistant organisms
MW Pletz, C Eckmann, S Hagel, HJ Heppner, K Huber, W Kämmerer, ...
Deutsche Medizinische Wochenschrift (1946) 140 (13), 975-981, 2015
132015
Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems-a new approach
MH Wilke, R Grube
European journal of medical research 15, 564-570, 2010
132010
Clinical and economic burden of surgical site infections in inpatient care in Germany: A retrospective, cross-sectional analysis from 79 hospitals
C Eckmann, A Kramer, O Assadian, S Flessa, C Huebner, K Michnacs, ...
PLoS One 17 (12), e0275970, 2022
122022
Procalcitonin as a tool for the assessment of successful therapy of severe sepsis: an analysis using clinical routine data
KF Bodmann, M Schenker, W Heinlein, MH Wilke
Medizinische Klinik-Intensivmedizin und Notfallmedizin 113, 533-541, 2018
112018
Limits of the G-DRG system to reflect Complexity in German University Hospitals
MM Lerch, M Rathmayer, B Siegmund, M Wilke, H Wedemeyer, ...
Zeitschrift fur Gastroenterologie 58 (8), 747-753, 2020
92020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20